Medline Inc. logo
MDLNMedline Inc.

The forward PE ratio is 26.62 as of Thursday, July 9, 2026.

Forward PE Ratio (26.62) = Close Price ($40.85) / Consensus Forward EPS ($1.51)

MDLN Forward PE Ratio Metrics

FORWARD PE RATIO

26.62

MDLN Competitors' Forward PE Ratio

MDLN

Medline Inc.

Current

Market Cap

$34.54B

Forward PE Ratio

26.62

IQV

IQVIA Holdings Inc.

vs MDLN

Market Cap

$34.88B

Forward PE Ratio

15.90

CNC

Centene Corp.

vs MDLN

Market Cap

$33.38B

Forward PE Ratio

19.16

ZTS

Zoetis Inc.

vs MDLN

Market Cap

$31.48B

Forward PE Ratio

10.91

A

Agilent Technologies, Inc.

vs MDLN

Market Cap

$37.73B

Forward PE Ratio

21.31

VEEV

Veeva Systems Inc.

vs MDLN

Market Cap

$30.82B

Forward PE Ratio

23.70

MRNA

Moderna, Inc.

vs MDLN

Market Cap

$30.38B

Forward PE Ratio

N/A

RMD

ResMed Inc.

vs MDLN

Market Cap

$30.24B

Forward PE Ratio

18.53

GEHC

GE HealthCare Technologies Inc.

vs MDLN

Market Cap

$29.43B

Forward PE Ratio

13.25

BIIB

Biogen Inc.

vs MDLN

Market Cap

$29.37B

Forward PE Ratio

13.80

Trailing vs Forward

Trailing P/E

33.3

reported TTM EPS

Forward P/E

26.6

consensus next-FY EPS

The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.51 implies +24.8% EPS growth vs the reported trailing $1.21.

Forward P/E by Fiscal Year

View All Analyst Estimates

At today's $40.85 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.

Fiscal year endConsensus EPSEstimate rangeAnalystsImplied P/E
2026-12-31$1.51$1.45 – $1.561527.0x
2027-12-31$1.66$1.59 – $1.701524.6x
2028-12-31$1.87$1.65 – $2.10921.8x

Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.

Forward PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Forward PE Ratio FAQ

What is the forward PE ratio for Medline Inc. (MDLN)?
The forward PE ratio for MDLN stock is 26.62.

About Medline Inc.

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Northfield, IL
45,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
James Boyle